GDPD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.765400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.441400E-01
Normal-vs-Stage2
9.148000E-01
Normal-vs-Stage3
1.442570E-01
Normal-vs-Stage4
6.871400E-01
Stage1-vs-Stage2
4.260000E-02
Stage1-vs-Stage3
7.957600E-02
Stage1-vs-Stage4
5.401400E-01
Stage2-vs-Stage3
3.111200E-01
Stage2-vs-Stage4
4.863800E-01
Stage3-vs-Stage4
1.983580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.632600E-01
Normal-vs-AfricanAmerican
6.346800E-01
Normal-vs-Asian
6.044800E-01
Caucasian-vs-AfricanAmerican
6.836000E-01
Caucasian-vs-Asian
1.514610E-01
AfricanAmerican-vs-Asian
2.157400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.103200E-01
Normal-vs-Female
9.647400E-01
Male-vs-Female
4.494000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.150400E-01
Normal-vs-Age(41-60Yrs)
6.908400E-01
Normal-vs-Age(61-80Yrs)
9.658800E-01
Normal-vs-Age(81-100Yrs)
9.297200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.495800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.263400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.012200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.005150E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.821400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.512000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.747600E-01
Normal-vs-Daily Drinker
6.683600E-01
Normal-vs-Weekly Drinker
7.706200E-01
Normal-vs-Occasional Drinker
4.676800E-01
Normal-vs-Social Drinker
6.674000E-01
Non Drinker-vs-Daily Drinker
8.318000E-01
Non Drinker-vs-Weekly Drinker
9.877000E-01
Non Drinker-vs-Occasional Drinker
4.427500E-02
Non Drinker-vs-Social Drinker
2.101200E-01
Daily Drinker-vs-Weekly Drinker
8.932600E-01
Daily Drinker-vs-Occasional Drinker
4.082000E-02
Daily Drinker-vs-Social Drinker
1.924770E-01
Weekly Drinker-vs-Occasional Drinker
6.323700E-02
Weekly Drinker-vs-Social Drinker
2.434800E-01
Occasional Drinker-vs-Social Drinker
6.127400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.111200E-01
Normal-vs-Grade 2
1.044410E-01
Normal-vs-Grade 3
6.914400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.082200E-02
Grade 1-vs-Grade 3
7.787500E-02
Grade 1-vs-Grade 4
2.111200E-01
Grade 2-vs-Grade 3
1.614980E-01
Grade 2-vs-Grade 4
1.044410E-01
Grade 3-vs-Grade 4
6.914400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.140400E-01
Normal-vs-NonDiabetic
8.914800E-01
Diabetic-vs-NonDiabetic
9.057000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.641600E-01
Normal-vs-NoPancreatitis
8.796000E-01
Pancreatitis-vs-NoPancreatitis
4.382400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.959400E-01
Normal-vs-N1
9.121400E-01
N0-vs-N1
8.626400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.261200E-01
Normal-vs-TP53-NonMutant
4.699800E-01
TP53-Mutant-vs-TP53-NonMutant
5.524200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
